{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:41Z","timestamp":1787003021438,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":444,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41436-020-0890-6","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T19:03:28Z","timestamp":1593457408000},"page":"1830-1837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Patient and family social media use surrounding a novel treatment for a rare genetic disease: a qualitative interview study"],"prefix":"10.1016","volume":"22","author":[{"given":"Alexander A.","family":"Iyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Barzilay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1005-5008","authenticated-orcid":false,"given":"Holly K.","family":"Tabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41436-020-0890-6_bb0010","author":"Lunn"},{"key":"10.1038\/s41436-020-0890-6_bb0015","author":"Sugarman"},{"key":"10.1038\/s41436-020-0890-6_bb0020","author":"Hoy"},{"key":"10.1038\/s41436-020-0890-6_bb0025","author":"Corey"},{"key":"10.1038\/s41436-020-0890-6_bb0030","author":"Finkel"},{"key":"10.1038\/s41436-020-0890-6_bb0035","author":"Darras"},{"key":"10.1038\/s41436-020-0890-6_bb0040","author":"Hach\u00e9"},{"key":"10.1038\/s41436-020-0890-6_bb0045","unstructured":"Thomas K. Costly drug for fatal muscular disease wins F.D.A. approval. The New York Times. 30 December 2016. https:\/\/www.nytimes.com\/2016\/12\/30\/business\/spinraza-price.html. Accessed 16 December 2019."},{"key":"10.1038\/s41436-020-0890-6_bb0050","author":"Pacione"},{"key":"10.1038\/s41436-020-0890-6_bb0055","author":"Burgart"},{"key":"10.1038\/s41436-020-0890-6_bb0060","author":"Smailhodzic"},{"key":"10.1038\/s41436-020-0890-6_bb0065","author":"Moorhead"},{"key":"10.1038\/s41436-020-0890-6_bb0070","unstructured":"Pew Research Center. Peer-to-peer health care. February 2011. https:\/\/www.pewresearch.org\/internet\/2011\/02\/28\/peer-to-peer-health-care-2\/. Accessed 4 March 2020."},{"key":"10.1038\/s41436-020-0890-6_bb0075","author":"Khouri"},{"key":"10.1038\/s41436-020-0890-6_bb0080","author":"Jacobs"},{"key":"10.1038\/s41436-020-0890-6_bb0085","author":"Gundersen"},{"key":"10.1038\/s41436-020-0890-6_bb0090","author":"Barton"},{"key":"10.1038\/s41436-020-0890-6_bb0095","author":"Pelentsov"},{"key":"10.1038\/s41436-020-0890-6_bb0100","author":"High"},{"key":"10.1038\/s41436-020-0890-6_bb0105","author":"Anguela"},{"key":"10.1038\/s41436-020-0890-6_bb0110","article-title":"The SAGE handbook of qualitative research","year":"2011"},{"key":"10.1038\/s41436-020-0890-6_bb0115","unstructured":"Silverman D. Doing qualitative research: a practical handbook. 4th ed. Thousand Oaks, CA: SAGE; 2013."},{"key":"10.1038\/s41436-020-0890-6_bb0120","series-title":"Designing and conducting mixed methods research","author":"Creswell","year":"2017"},{"key":"10.1038\/s41436-020-0890-6_bb0125","series-title":"Interviewing as qualitative research: a guide for researchers in education and the social sciences","author":"Seidman","year":"2006"},{"key":"10.1038\/s41436-020-0890-6_bb0130","author":"Hsieh"},{"key":"10.1038\/s41436-020-0890-6_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/146879410100100307","article-title":"Thematic networks: an analytic tool for qualitative research","volume":"1","author":"Attride-Stirling","year":"2001","journal-title":"Qual Res"},{"key":"10.1038\/s41436-020-0890-6_bb0140","unstructured":"Epstein SG. Patient groups and health movements. In: Hackett EJ, Amsterdamska O, Lynch M, Wajcman J, editors. The handbook of science and technology studies. Cambridge: MIT Press; 2008. p. 499\u2013539."},{"key":"10.1038\/s41436-020-0890-6_bb0145","unstructured":"National Organization for Rare Disorders. History of leadership. https:\/\/rarediseases.org\/about\/what-we-do\/history-leadership\/. Accessed 5 March 2020."},{"key":"10.1038\/s41436-020-0890-6_bb0150","author":"Vandeborne"},{"key":"10.1038\/s41436-020-0890-6_bb0155","author":"Vosoughi"},{"key":"10.1038\/s41436-020-0890-6_bb0160","author":"Chou"},{"key":"10.1038\/s41436-020-0890-6_bb0165","author":"Rupert"},{"key":"10.1038\/s41436-020-0890-6_bb0170","unstructured":"Fazzini K, Farr C. Facebook recently closed a loophole that allowed third parties to discover the names of people in private, \u201cclosed\u201d Facebook groups. CNBC. 12 July 2018. https:\/\/www.cnbc.com\/2018\/07\/11\/facebook-private-groups-breast-cancer-privacy-loophole.html. Accessed 5 March 2020."},{"key":"10.1038\/s41436-020-0890-6_bb0175","unstructured":"Trotter F. SicGRL vulnerability is still not fixed. Light Collective. 12 September 2019. https:\/\/lightcollective.org\/2019\/09\/12\/sicgrl-update\/. Accessed 23 May 2020."},{"key":"10.1038\/s41436-020-0890-6_bb0180","unstructured":"Shead S. People with epilepsy targeted in Twitter attack. BBC News. 18 December 2019. https:\/\/www.bbc.com\/news\/technology-50835214."},{"key":"10.1038\/s41436-020-0890-6_bb0185","author":"Nicholl"},{"key":"10.1038\/s41436-020-0890-6_bb0190","unstructured":"Novartis. AveXis receives FDA approval for Zolgensma\u00ae, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA). 24 May 2019. https:\/\/www.novartis.com\/news\/media-releases\/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma. Accessed 5 March 2020."},{"key":"10.1038\/s41436-020-0890-6_bb0195","unstructured":"Roche. FDA grants priority review to Roche\u2019s risdiplam for spinal muscular atrophy. 25 November 2019. https:\/\/www.roche.com\/media\/releases\/med-cor-2019-11-25.htm. Accessed 5 March 2020."},{"key":"10.1038\/s41436-020-0890-6_bb0200","unstructured":"Joseph A, Silverman E. Lottery like no other offers a cutting-edge medicine \u2014 with lives on the line. STAT News. 7 February 2020. https:\/\/www.statnews.com\/2020\/02\/07\/a-lottery-like-no-other-offers-up-a-cutting-edge-medicine-with-lives-on-the-line\/. Accessed 23 May 2020."},{"key":"10.1038\/s41436-020-0890-6_bb0205","author":"Jamison"},{"key":"10.1038\/s41436-020-0890-6_bb0210","author":"Schumacher"},{"key":"10.1038\/s41436-020-0890-6_bb0215","unstructured":"Facebook. Help center. https:\/\/www.facebook.com\/help\/?helpref=hc_global_nav. Accessed 25 March 2020."}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41436-020-0890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41436-020-0890-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021007802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021007802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41436-020-0890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:50:35Z","timestamp":1761097835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021007802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1098360021007802"],"URL":"https:\/\/doi.org\/10.1038\/s41436-020-0890-6","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient and family social media use surrounding a novel treatment for a rare genetic disease: a qualitative interview study","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41436-020-0890-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics","name":"copyright","label":"Copyright"}]}}